ArticleFrontiers in pharmacology2024

The baseline hemoglobin level is a positive biomarker for immunotherapy response and can improve the predictability of tumor mutation burden for immunotherapy response in cancer.

Yin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.